Organogenesis Holdings Inc (ORGO) — Capital Reinvestment Ratio
Organogenesis Holdings Inc (ORGO) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow ($3.08 Million) in capital expenditures ($2.23 Million). Check Organogenesis Holdings Inc (ORGO) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Organogenesis Holdings Inc Capital Reinvestment Ratio (2020–2024)
This chart tracks Organogenesis Holdings Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see ORGO operating cash flow.
Annual Capital Reinvestment Ratio for Organogenesis Holdings Inc (2020–2024)
Year-by-year Capital Reinvestment Ratio for Organogenesis Holdings Inc from 2020 to 2024. See ORGO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.71x | $14.21 Million | $10.03 Million | ▼ -10.4% |
| 2023 | 0.79x | $30.92 Million | $24.36 Million | ▼ -42.2% |
| 2022 | 1.36x | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 0.50x | $61.98 Million | $31.22 Million | ▼ -84.4% |
| 2020 | 3.23x | $5.47 Million | $17.68 Million | — |